The role of angiogenesis, laminin and CD44 expression in metastatic behavior of early-stage low-grade invasive breast carcinomas

Cancer Letters

Volumn 121, Issue 2, 1997, Pages 119-123

  Özer, Erdener ^a   Canda, Tülay ^a   Kurtolu, Banu ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Breast cancer; CD44; Immunohistochemistry; Laminin; Stereology

Indexed keywords

BLOOD CLOTTING FACTOR 8; HERMES ANTIGEN; LAMININ;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STEREOMETRY; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANTIGENS, CD44; BREAST NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; LAMININ; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 0344542076     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00346-7     Document Type: Article

References (20)

1. Axelsson K., Ljung B.E., Moore D.H., Thor A.D., Chew K.L., Edgerton S.M., Smith H.S., Mayall B.H. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J. Natl. Cancer Inst. 8:1995;997-1008.
2. Wu J. Apoptosis and angiogenesis: two promising tumor markers in breast cancer. Anticancer Res. 16:1996;2233-2239.
3. Gorczyca W., Holm R., Nesland J.M. Laminin production and fibronectin immunoreactivity in breast carcinomas. Anticancer Res. 13:1993;851-858.
4. Gui J.B., Puddefoot J.R., Vinson G.B., Wells C.A., Carpenter R. In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. Br. J. Surg. 82:1995;1192-1196.
5. Gasparin G., Barbareshi M., Boracchi P., Bevilacqua P., Verderio P., Dalla-Palma P., Menard S. 67-kDa laminin receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer. Int. J. Cancer. 60:1995;604-610.
6. Dall P., Heider K.H., Sinn H.P., Scroch-Angel P., Adolf G., Kaufmann M., Herlich P., Ponta H. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int. J. Cancer. 60:1995;471-477.
7. Shildberg F.W., Meyer G., Piltz S., Koebe H.G. Surgical treatment of metastasis: general consideration and results. Surg. Today. 25:1995;1-10.
8. Weibel E.R. Principles and methods for the morphometric study of the lung and the other organs. Lab. Invest. 12:1963;131-155.
9. Christensen L. The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix. APMIS (Suppl.). 26:1992;1-39.
10. Schumacher U., Horny H.P., Horst H.A., Herlich P.A., Kaiserlink E. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer. Eur. J. Surg. Oncol. 22:1996;259-261.
11. Joensuu H., Klemi P.J., Toikkanen S., Jalkanen S. Glycoprotein CD44 expression and its association with survival in breast cancer. Am. J. Pathol. 143:1993;867-874.
12. Regidor P.A., Callies R., Regidor M., Gunther U., Zoller M., Schindler A.E. Expression of CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters. Arch. Gynecol. Obstet. 258:1996;125-135.
13. Tempfer C., Losch A., Heinzl H., Hausler G., Hanzal H., Kolbl H., Breitenecker G., Kainz C. Prognostic value of immunohistochemically detected CD44 isoforms Cd44v5, CD44v6 and CD44v8 in human breast cancer. Eur. J. Cancer. 32A:1996;2023-2025.
14. Hall N.R., Fish D.R., Hunt N., Goldin R.D., Guilou P.J., Monson J.R. Is the relationship between angiogenesis and metastasis in breast cancer real. Surg. Oncol. 1:1992;223-229.
15. Gasparin G., Harris A.L. Clinical importance of determination of tumor angiogenesis in breast carcinoma: much more than a new diagnostic tool. J. Clin. Oncol. 13:1995;765-782.
16. Ellis L.M., Fidler I.J. Angiogenesis and breast cancer metastasis. Lancet. 346:1995;388-390.
17. Heimann R., Ferguson D., Powers C., Recant W.M., Weicselbaum R.R., Hellman S. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J. Natl. Cancer Inst. 88:1996;1764-1769.
18. Aranda F.I., Laforga J.B. Microvessel quantitation in breast ductal invasive carcinoma. Correlation with proliferative activity, hormonal receptors and lymph node metastases. Pathol. Res. Pract. 192:1996;124-129.
19. Toi M., Kashitani J., Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer. 55:1993;371-374.
20. Jain R.K. Determination of tumor blood flow: a review. Cancer. 48:1988;2641-2658.